These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 36931117)
21. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors. Baek YH; Song MS; Lee EY; Kim YI; Kim EH; Park SJ; Park KJ; Kwon HI; Pascua PN; Lim GJ; Kim S; Yoon SW; Kim MH; Webby RJ; Choi YK J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319 [TBL] [Abstract][Full Text] [Related]
22. Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K. Tran-To Su C; Ouyang X; Zheng J; Kwoh CK BMC Bioinformatics; 2013; 14 Suppl 16(Suppl 16):S7. PubMed ID: 24564719 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A. Wang K; Lei Z; Zhao L; Chen B; Yang F; Liu K; Zhu H; Zhao H; Cao R; Zhang K; Tian Y Eur J Med Chem; 2020 Jan; 185():111841. PubMed ID: 31708183 [TBL] [Abstract][Full Text] [Related]
24. Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity. Ju H; Xiu S; Ding X; Shang M; Jia R; Huang B; Zhan P; Liu X Eur J Med Chem; 2020 Feb; 187():111940. PubMed ID: 31835169 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and evaluation of carboxyl-modified oseltamivir derivatives with improved lipophilicity as neuraminidase inhibitors. Wang B; Wang K; Meng P; Hu Y; Yang F; Liu K; Lei Z; Chen B; Tian Y Bioorg Med Chem Lett; 2018 Nov; 28(21):3477-3482. PubMed ID: 30266543 [TBL] [Abstract][Full Text] [Related]
26. Discovery andsynthesis of novel benzoylhydrazone neuraminidase inhibitors. Fu SK; Cheng LP Bioorg Med Chem Lett; 2024 Jun; 105():129743. PubMed ID: 38608962 [TBL] [Abstract][Full Text] [Related]
27. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies. Ye J; Yang X; Xu M; Chan PK; Ma C Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744 [TBL] [Abstract][Full Text] [Related]
28. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation. Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747 [TBL] [Abstract][Full Text] [Related]
29. The current strategies of optimization of oseltamivir against mutant neuraminidases of influenza A:A review. Wang K; Zhang H; Tian Y Eur J Med Chem; 2022 Dec; 243():114711. PubMed ID: 36055001 [TBL] [Abstract][Full Text] [Related]
30. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442 [TBL] [Abstract][Full Text] [Related]
31. The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus. Kannan S; Kolandaivel P J Biomol Struct Dyn; 2018 Dec; 36(16):4255-4269. PubMed ID: 29199545 [TBL] [Abstract][Full Text] [Related]
32. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir. Park JW; Jo WH J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and Biological Evaluation of Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617 [TBL] [Abstract][Full Text] [Related]
34. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase. Li L; Li Y; Zhang L; Hou T J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323 [TBL] [Abstract][Full Text] [Related]
35. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues. Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597 [TBL] [Abstract][Full Text] [Related]
36. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Collins PJ; Haire LF; Lin YP; Liu J; Russell RJ; Walker PA; Skehel JJ; Martin SR; Hay AJ; Gamblin SJ Nature; 2008 Jun; 453(7199):1258-61. PubMed ID: 18480754 [TBL] [Abstract][Full Text] [Related]
37. Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance. McKimm-Breschkin JL Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):25-36. PubMed ID: 23279894 [TBL] [Abstract][Full Text] [Related]
38. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus. Shu M; Lin Z; Zhang Y; Wu Y; Mei H; Jiang Y J Mol Model; 2011 Mar; 17(3):587-92. PubMed ID: 20517627 [TBL] [Abstract][Full Text] [Related]
39. Discovery of novel thiophene derivatives as potent neuraminidase inhibitors. Zhong ZJ; Hu XT; Cheng LP; Zhang XY; Zhang Q; Zhang J Eur J Med Chem; 2021 Dec; 225():113762. PubMed ID: 34411893 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors. Wang Z; Cheng LP; Zhang XH; Pang W; Li L; Zhao JL Bioorg Med Chem Lett; 2017 Dec; 27(24):5429-5435. PubMed ID: 29141777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]